Skip to content

Thrombus Imaging and Treatment Analytics in Neurology

Thrombus Imaging and Treatment Analytics in Neurology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05663281
Acronym
Titan
Enrollment
100
Registered
2022-12-23
Start date
2022-12-15
Completion date
2027-12-31
Last updated
2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thrombosis, Thrombus, Brain

Keywords

Thrombus, Neuroimaging, High-resolution vessel wall imaging, Cerebral ischemia, Cerebral artery

Brief summary

In the present study, the investigators use high-resolution MR vessel wall imaging, and select patients with cerebral and cervical artery occlusion to investigate the relationship between the imaging appearance of thrombus and the various outcome of recanalization treatment.

Detailed description

Cerebral ischemic stroke resulting from thrombosis causes high disability and mortality. There are few biomarkers to evaluate arterial thrombophilia until now. Previous studies have demonstrated that atherosclerotic plaque rupture and erosion are major etiologies initiating thrombosis. Based on previous works targeting the role of plaque and blood flow in cerebrovascular disease, in the present study, the investigators use high-resolution MR vessel wall imaging, and select patients with cerebral and cervical artery occlusion to explore the relationship between the imaging appearance of thrombus and the various outcome of recanalization treatment. The study's objective was to solve the challenges in the mechanism of thrombus features and the outcome of recanalization therapy, thus helping improve the primary and secondary prevention of cerebrovascular disease.

Interventions

DIAGNOSTIC_TESTthrombus imaging appearance

Imaging appearance of intracranial and/or extracranial arterial thrombus

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Extracranial and/or intracranial artery occlusion confirmed by angiography * Available for magnetic resonance high-resolution vessel wall imaging * Written informed consent obtained

Exclusion criteria

* Extracranial and/or intracranial artery mild to moderate stenosis * Pregnant women * Restenosis or occlusion after artery stenting placement

Design outcomes

Primary

MeasureTime frameDescription
Rate of Successful Recanalization1-3 YearsAntegrade blood flow through the recanalized portion was assessed by thrombolysis in myocardial infarction (TIMI) score or thrombolysis in cerebral infarction (TICI) score. TIMI≥2 or TICI≥2b was defined as successful recanalization.
Ischemic Stroke Occurrence1-3 YearsIschemic stroke occurrence during follow-up period which was confirmed by neuroimaging

Secondary

MeasureTime frameDescription
Number of Participants with Adverse Events1-3 Yearshemorrhagic or ischemic stroke after recanalization treatment

Countries

China

Contacts

Primary ContactJinhao Lyu, M.D.
330322990@qq.com+8615903562929

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026